Commerce Bank bought a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 3,863 shares of the insurance provider’s stock, valued at approximately $1,534,000.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Montag A & Associates Inc. increased its position in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares during the last quarter. Johnson Financial Group Inc. bought a new stake in shares of Humana in the 2nd quarter worth about $26,000. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana in the 4th quarter worth about $27,000. Trust Co. of Vermont purchased a new position in shares of Humana during the 2nd quarter worth about $28,000. Finally, Reflection Asset Management bought a new position in Humana during the 4th quarter valued at about $29,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Humana Stock Performance
HUM opened at $388.92 on Wednesday. The firm has a 50 day moving average of $383.88 and a two-hundred day moving average of $285.00. The firm has a market capitalization of $46.70 billion, a PE ratio of 36.79, a P/E/G ratio of 2.20 and a beta of 0.72. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.
Analyst Ratings Changes
A number of analysts recently weighed in on HUM shares. Guggenheim increased their price objective on shares of Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Evercore raised shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price objective for the company in a research note on Wednesday, July 29th. Piper Sandler raised Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target for the company in a research report on Thursday, July 30th. Sanford C. Bernstein reissued an “outperform” rating and issued a $425.00 price objective on shares of Humana in a research report on Wednesday, June 3rd. Finally, Morgan Stanley raised Humana from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $249.00 to $370.00 in a research report on Tuesday, August 4th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $403.91.
Check Out Our Latest Stock Report on Humana
Humana Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Read More
- Five stocks we like better than Humana
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
